Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 7 open reading frame 73 pseudogene (ENSG00000271128) is systematically classified as a **pseudogene**, which is a segment of DNA homologous to a functional gene but rendered nonfunctional by disabling mutations (such as frameshifts or premature stop codons)[2][4]. Pseudogenes are common genomic elements, traditionally considered “gene relics” without protein-coding capacity, and are not expected to produce functional proteins. Only a minority of pseudogenes have demonstrable regulatory RNA functions, and most have no established role in physiology or disease[1][4][6]. There is no evidence supporting functional protein-level activity, therapeutic targeting, or clinical utility for this pseudogene. Summary: ENSG00000271128 is a pseudogene, not a true druggable target, and its inclusion as a therapeutic target is incorrect. It is best categorized as a nonfunctional genomic element with no current biomedical relevance[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 7 open reading frame 73 pseudogene.